Navigation Links
Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project
Date:12/7/2009

QUINCY, Mass., Dec. 7 /PRNewswire/ -- Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana. Notably, among the 19 integrated biorefinery projects that won funding or loan guarantees, Myriant was the only award focused exclusively on biobased chemicals rather than biofuels.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091021/NE96331LOGO )

The DOE and other third-party studies have previously identified biobased Succinic Acid as a priority among the top 12 chemicals by market size that can be derived from biomass. Succinic Acid is used in a wide variety of applications including plastics, fibers, polyesters and pigments.

Myriant's production of biobased Succinic Acid will utilize both local sorghum and carbon dioxide (CO2) to displace petroleum-based feedstocks, using less energy than its petroleum alternative. In addition to the energy savings, by consuming CO2 rather than producing it via oil refining methods, Myriant's process dramatically reduces lifecycle greenhouse gas emissions.

"We are grateful for the validation of our technology embodied in the award by the DOE," said Stephen J. Gatto, Chairman and Chief Executive Officer of Myriant. "We applaud their recognition of the importance of biobased chemicals as a leading component of biorefineries. Our Succinic Acid platform provides a "win-win" solution in terms of cost, environmental benefits and reduction in our dependence on imported oil and puts critical jobs to work right here in the United States."

The award will help fund the construction of Myriant's Succinic Acid plant at the Port of Lake Providence, Louisiana. "The Port and the State of Louisiana have been extraordinary partners, and we expect the site, immediately adjacent to the Mississippi River, to be the foundation of a large biotech corridor in Louisiana," added Mr. Gatto. "We're very excited about bringing this technology and over 250 construction and full time operating jobs to the community."

"The Port of Lake Providence is tremendously excited to be working with Myriant on this very important project," added Wyly Gilfoil, Director of the Lake Providence Port Commission. "We're delighted to see the assets of the Port and the region used in this manner to bring much needed high tech industries and jobs to the community."

About Myriant Technologies

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable manufacturing of high-value specialty chemicals. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant will next begin commercial production of its second product, biobased Succinic Acid; samples are currently available by contacting productinfo@myriant.com. Myriant is headquartered in Quincy, Massachusetts. Further information is available at www.myriant.com.


Contact:  Samuel G. McConnell
          Sr. Vice President, Corporate Development
          617-657-5207

SOURCE Myriant Technologies LLC


'/>"/>
SOURCE Myriant Technologies LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants
2. Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
3. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
4. Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
5. Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies
6. Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
7. Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
8. Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics
9. Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
10. Senesco Technologies, Inc. Announces Management Change
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" ... Liver Congress ("ILC") 2017 of the European Association for the ... on the positive effects of PBI-4050 on reduction of ... metabolic syndrome. ... Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This ...
(Date:4/20/2017)... , April 20, 2017 Dutch philosopher Koert van ... ,Next Nature, at the University of Technology in Eindhoven - has written ... this letter, he calls on humanity to avoid becoming a slave and victim ... ... Dutch philosopher Koert van Mensvoort – founder of the ...
(Date:4/19/2017)... ... April 18, 2017 , ... A number of new instruments ... which is part of the Protein and Cell Analysis Education Webinar Series , ... this technology fits in current and future applications. , Many flow cytometers have ...
(Date:4/19/2017)... ... April 19, 2017 , ... ThermaGenix, the PCR Improvement Company, ... to several other early achievements at ThermaGenix, including the business formation and licensing ... ThermaGenix will use proceeds from the Series A-1 round to:, ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):